Janus Kinase Inhibitors Promising for Difficult-to-Treat RA
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
CDC Advisers Consider Boosters for Immune-Compromised Americans
Will an App to Monitor Patient Outcomes Improve RA Disease Activity?
Learn to Share Your Voice at Advocacy 101
2022 Physician Fee Schedule Proposed Rule Released
Executive Order Targets Prescription Drugs & Health Insurance to Promote Competition
Steven Echard Shares ACR Collaborative Plans at Florida Society Meeting
2022 Proposed Rule for the Quality Payment Program Released
- 1
- 2
- 3
- …
- 678
- Next Page »